Aptus Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE15XJ01010
  • NSEID:
  • BSEID: 544529
INR
487.45
9.55 (2.0%)
BSENSE

Nov 20

BSE+NSE Vol: 8400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039782,
    "name": "Aptus Pharma",
    "stock_name": "Aptus Pharma",
    "full_name": "Aptus Pharma Ltd",
    "name_url": "stocks-analysis/aptus-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "487.45",
    "chg": 9.55,
    "chgp": "2.0%",
    "dir": 1,
    "prev_price": "477.90",
    "mcapval": "820.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544529,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE15XJ01010",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": 8400,
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aptus-pharma-10039782-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "10039782",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/aptus-pharma-10039782"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Equity Shares On Preferential Basis Under Regulation 30 Of SEBI LODR Regulations 2015",
      "datetime": "12-Nov-2026",
      "details": "Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations 2015",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting For Allotment Of Equity Shares On Preferential Basis",
      "datetime": "06-Nov-2026",
      "details": "Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Intimation of Board Meeting for allotment of Equity Shares on Preferential Basis",
      "source": "BSE"
    },
    {
      "caption": "Receipt Of In-Principle Approval For Preferential Issue",
      "datetime": "30-Oct-2026",
      "details": "Receipt of In-Principle Approval for Preferential Issue",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aptus Pharma Ltd has announced <strong>3:2</strong> bonus issue, ex-date: 12 May 26",
          "dt": "2026-05-12",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Equity Shares On Preferential Basis Under Regulation 30 Of SEBI LODR Regulations 2015

12-Nov-2026 | Source : BSE

Outcome of Board Meeting - Allotment of Equity Shares on Preferential Basis under Regulation 30 of SEBI LODR Regulations 2015

Board Meeting Intimation for Intimation Of Board Meeting For Allotment Of Equity Shares On Preferential Basis

06-Nov-2026 | Source : BSE

Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 inter alia to consider and approve Intimation of Board Meeting for allotment of Equity Shares on Preferential Basis

Receipt Of In-Principle Approval For Preferential Issue

30-Oct-2026 | Source : BSE

Receipt of In-Principle Approval for Preferential Issue

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aptus Pharma Ltd has announced 3:2 bonus issue, ex-date: 12 May 26

stock-summary
RIGHTS

No Rights history available